What dose of lidocaine can cause Local Anesthetic Systemic Toxicity (LAST)?

Lidocaine Dosing Thresholds for Local Anesthetic Systemic Toxicity (LAST)

LAST can occur when plasma lidocaine concentrations exceed 5 μg/mL, which typically corresponds to doses above 4.5 mg/kg (without epinephrine) or 7 mg/kg (with epinephrine), though toxicity is multifactorial and depends critically on route of administration, rate of injection, patient weight calculation method, and individual risk factors 1, 2.

Dose-Dependent Toxicity Thresholds

The relationship between plasma concentration and toxicity follows a predictable progression 1:

• 5 μg/mL: Tingling tongue/lips, light-headedness
• 10 μg/mL: Tinnitus, slurred speech, muscle twitching
• 15 μg/mL: Loss of consciousness, respiratory arrest, coma
• 20 μg/mL: Myocardial depression, cardiac arrhythmias
• 25 μg/mL: Ventricular arrest, death

Maximum Recommended Doses by Formulation

Without Epinephrine

• Adults: Maximum 4.5 mg/kg or 300 mg total, whichever is lower 2
• Children: Maximum 4.5 mg/kg 2

With Epinephrine (1:80,000 or 1:100,000)

• Adults: Maximum 7 mg/kg or 500 mg total 2, 3
• Children: Maximum 7 mg/kg 2
• Practical limit: The epinephrine ceiling typically restricts administration to 6-7 cartridges (2.2 mL each) regardless of calculated dose 3

Critical Dosing Principles

Use ideal body weight for all dose calculations, not actual body weight 1. This is calculated as:

• Men: height (cm) - 100
• Women: height (cm) - 105

Do not use IV lidocaine in patients <40 kg, and never exceed 120 mg/hour for any patient 1.

High-Risk Administration Routes

The route of administration dramatically affects toxicity risk, even at "safe" doses 4:

1. Highest risk: Topical oropharyngeal application (35.59% of LAST cases) and subcutaneous infiltration (38.98% of cases) 4
2. Moderate risk: Highly vascular nerve blocks (intercostal, paracervical)
3. Lower risk: Peripheral nerve blocks with ultrasound guidance

Rapid injection increases toxicity risk independent of total dose 1. Loading doses must be given over at least 10 minutes 1.

Patient-Specific Risk Factors That Lower Toxic Threshold

These conditions substantially reduce the effective toxic dose 1, 2, 3:

• Cardiac disease (reduced ability to compensate for AV conduction changes)
• Hepatic impairment (reduced metabolism of amide local anesthetics)
• Renal disease (altered clearance)
• Age extremes (elderly have reduced clearance; use reduced doses)
• Pregnancy (increased uptake rate)
• Low body weight (<40 kg absolute contraindication for IV use)
• Seizure disorders (lower CNS toxicity threshold)

Combined Local Anesthetic Use

When combining multiple amide local anesthetics, use the fractional dose rule 3:

(Dose of Drug A / Maximum Dose of Drug A) + (Dose of Drug B / Maximum Dose of Drug B) ≤ 1

This accounts for additive systemic toxicity, which is the primary concern—not metabolic pathway differences 3. The principal reasons to avoid combining agents include unnecessary drug exposure, more complex calculations, and incremental hypersensitivity risk 3.

Timing Restrictions with Regional Anesthesia

Do not combine IV lidocaine with other local anesthetic interventions 1:

• Wait 4 hours after nerve/fascial plane blocks before starting IV lidocaine
• Wait 4 hours after stopping IV lidocaine before performing nerve blocks
• Wait 4 hours after stopping IV lidocaine before giving boluses into wound/epidural catheters
• Remove topical 5% lidocaine patches before starting IV lidocaine
• Continuous infusions (without boluses) through catheters may start 30 minutes after stopping IV lidocaine

Real-World Toxicity Patterns

Recent surveillance data reveals critical patterns 5, 4:

• Lidocaine causes 59-75% of all LAST cases, primarily from oropharyngeal, topical, and infiltration use 5, 4
• Overdosing accounts for 67.8% of LAST events, with lidocaine representing 75% of overdose cases 4
• Non-anesthesiologist administration is an increasing source of toxicity, particularly from local infiltration analgesia 5, 4

Case Example of Dangerous Dosing

A 40-year-old, 51 kg woman received 760 mg lidocaine in an outpatient setting—nearly triple the maximum recommended dose of 300 mg—resulting in seizure, tremors, paresthesias, and requiring lipid emulsion rescue 6. Another case involved 300 mg epidural lidocaine in a patient with ideal body weight of 40 kg (7.5 mg/kg, exceeding the 7 mg/kg maximum), causing loss of consciousness requiring lipid rescue 7.

Recognition and Immediate Management

Early CNS Symptoms (Plasma ~5-10 μg/mL)

• Perioral tingling, metallic taste
• Tinnitus, visual disturbances
• Agitation, confusion
• Slurred speech

Severe CNS Symptoms (Plasma ~10-15 μg/mL)

• Seizures (most common severe presentation: 50.85% of LAST cases) 4
• Loss of consciousness

Cardiovascular Symptoms (Plasma >15 μg/mL)

• Bradycardia, hypotension
• Arrhythmias
• Cardiac arrest

Treatment Algorithm

1. Stop local anesthetic administration immediately
2. Call for help and prepare lipid emulsion
3. Airway management is primary intervention: ensure oxygenation, support ventilation
4. Suppress seizures: benzodiazepines (avoid propofol in cardiovascular instability)
5. Administer 20% lipid emulsion for severe or cardiovascular LAST 1, 4:
   • Bolus: 1.5 mL/kg over 1 minute
   • Infusion: 0.25 mL/kg/min
   • Repeat bolus after 5 minutes if cardiovascular instability persists
   • Continue infusion until hemodynamic stability (maximum 12 mL/kg)
6. Standard ACLS with modifications: avoid vasopressin, reduce epinephrine doses (<1 μg/kg), avoid calcium channel blockers, beta-blockers, and local anesthetics

Lipid emulsion achieved 100% full recovery in LAST cases where it was used, compared to 73.81% with supportive care alone 4.

Critical Pitfalls to Avoid

1. Using actual body weight instead of ideal body weight in obese patients leads to overdosing 7
2. Rapid injection increases peak plasma levels even at "safe" total doses 1
3. Combining multiple local anesthetics without fractional dose calculation 3
4. Topical oropharyngeal use without dose tracking—this is the most common route causing LAST in non-anesthesiologist practice 4
5. Assuming 300 mg is always safe—this exceeds maximum dose in patients <67 kg 2
6. Failure to have lipid emulsion immediately available where local anesthetics are used 4